Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Feinberg

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The American Journal of Managed Care|June 3, 2014
Physician behavior impact when revenue shifted from drugs to servicesBruce Feinberg, Scott Milligan, Tim Olson, et al.
Journal of Medical Economics|October 5, 2019
Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agentsPranav Abraham, Jonathan Karl Kish, Beata Korytowsky, et al.
The Oncologist|March 11, 2022
Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology PracticesAndrew J Klink, Landon Z Marshall, Abdalla Aly, et al.
JCO Oncology Practice|March 9, 2022
The Use and Knowledge of Validated Geriatric Assessment Instruments Among US Community OncologistsAjeet Gajra, Yolaine Jeune-Smith, Stephanie Fortier, et al.
The Oncologist|April 25, 2019
Patterns of Care Among Real-World Patients with Metastatic Neuroendocrine TumorsAndrew J Klink, Bruce Feinberg, Hsing-Ting Yu, et al.
Biomarker Research|January 24, 2025
Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphomaNarendranath Epperla, Loretta J Nastoupil, Bruce Feinberg, et al.
British Journal of Haematology|May 15, 2026
Real-world treatment patterns and outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the REAL-AVA 3.5 studyCaroline Piatek, Abiola Oladapo, Scott Kolodny, et al.
JCO Oncology Practice|April 11, 2020
Frequency and Causes of Burnout in US Community Oncologists in the Era of Electronic Health RecordsAjeet Gajra, Bela Bapat, Yolaine Jeune-Smith, et al.
Ejhaem|December 18, 2024
Real-world practitioner perceptions of CARTITUDE-4 results for patients with previously treated multiple myelomaAlexandrina Balanean, Samuel Baird, Brooke Dulka, et al.
The Oncologist|August 22, 2024
Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the USKim Saverno, Kristin M Zimmerman Savill, Cherrishe Brown-Bickerstaff, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The American Journal of Managed Care|June 3, 2014
Physician behavior impact when revenue shifted from drugs to servicesBruce Feinberg, Scott Milligan, Tim Olson, et al.
Journal of Medical Economics|October 5, 2019
Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agentsPranav Abraham, Jonathan Karl Kish, Beata Korytowsky, et al.
The Oncologist|March 11, 2022
Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology PracticesAndrew J Klink, Landon Z Marshall, Abdalla Aly, et al.
JCO Oncology Practice|March 9, 2022
The Use and Knowledge of Validated Geriatric Assessment Instruments Among US Community OncologistsAjeet Gajra, Yolaine Jeune-Smith, Stephanie Fortier, et al.
The Oncologist|April 25, 2019
Patterns of Care Among Real-World Patients with Metastatic Neuroendocrine TumorsAndrew J Klink, Bruce Feinberg, Hsing-Ting Yu, et al.
Biomarker Research|January 24, 2025
Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphomaNarendranath Epperla, Loretta J Nastoupil, Bruce Feinberg, et al.
British Journal of Haematology|May 15, 2026
Real-world treatment patterns and outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the REAL-AVA 3.5 studyCaroline Piatek, Abiola Oladapo, Scott Kolodny, et al.
JCO Oncology Practice|April 11, 2020
Frequency and Causes of Burnout in US Community Oncologists in the Era of Electronic Health RecordsAjeet Gajra, Bela Bapat, Yolaine Jeune-Smith, et al.
Ejhaem|December 18, 2024
Real-world practitioner perceptions of CARTITUDE-4 results for patients with previously treated multiple myelomaAlexandrina Balanean, Samuel Baird, Brooke Dulka, et al.
The Oncologist|August 22, 2024
Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the USKim Saverno, Kristin M Zimmerman Savill, Cherrishe Brown-Bickerstaff, et al.
Pageof 5